Abstract
Background and Objective: Bacitracin was discovered and named after a 7 year old American girl, Margaret Tracey in 1943 as Bacillus was isolated from her wounds. Bacillus licheniformis is usually present in soil and bird feathers. This bacterium is most commonly present around back plumage and chest of birds. There are different types of bacitracin but the one most potent is Bacitracin A. Bacitracin induced proteins are localized in bacterial membrane. Production of antibiotic initially stopped, resumed by induction of bacitracin induced protein but after few mitotic divisions microbes reverted to their vulnerable state. Induction of protein ceases after 4th hour of stationary phase. Immobilization is necessary for economic, process convenience and stability of the cell. Moreover, immobilization increases the ability of the cell to produce product in high quantity.
Conclusion: Maximum production of antibiotic was noted at pH 8 after 4 hours of incubation at various glucose concentrations in shake flask fermentation at 30°C when immobilized in polyacrylamide gel. Increase in antibiotic activity was also found with increase in use of cells. Efforts have been made to alter heterocyclic metal binding subunit of bacitracin by synthesizing heterocyclic building blocks that can be coupled to linear decapeptide and consequently cyclization by PCPTE biodomain of bacitracin. Derivatives of bacitracin showed antimicrobial activities indicating the possibility of overcoming existing limitations just by altering their heterocyclic subunit. Bioactivity and stability can be increased by modifying peptide backbone of compounds.
Keywords: Antibiotic, bacitracin, industrial, largescale, production, up scaling.
Graphical Abstract
Mini-Reviews in Medicinal Chemistry
Title:Up Scaling Strategies to Improve the Industrial Production of Bacitracin at Largescale
Volume: 17 Issue: 16
Author(s): Chandra Kant Sharma and Monika Sharma*
Affiliation:
- Department of Bioscience and Biotechnology, Faculty of Science and Technology, Banasthali University, Rajasthan 304022,India
Keywords: Antibiotic, bacitracin, industrial, largescale, production, up scaling.
Abstract: Background and Objective: Bacitracin was discovered and named after a 7 year old American girl, Margaret Tracey in 1943 as Bacillus was isolated from her wounds. Bacillus licheniformis is usually present in soil and bird feathers. This bacterium is most commonly present around back plumage and chest of birds. There are different types of bacitracin but the one most potent is Bacitracin A. Bacitracin induced proteins are localized in bacterial membrane. Production of antibiotic initially stopped, resumed by induction of bacitracin induced protein but after few mitotic divisions microbes reverted to their vulnerable state. Induction of protein ceases after 4th hour of stationary phase. Immobilization is necessary for economic, process convenience and stability of the cell. Moreover, immobilization increases the ability of the cell to produce product in high quantity.
Conclusion: Maximum production of antibiotic was noted at pH 8 after 4 hours of incubation at various glucose concentrations in shake flask fermentation at 30°C when immobilized in polyacrylamide gel. Increase in antibiotic activity was also found with increase in use of cells. Efforts have been made to alter heterocyclic metal binding subunit of bacitracin by synthesizing heterocyclic building blocks that can be coupled to linear decapeptide and consequently cyclization by PCPTE biodomain of bacitracin. Derivatives of bacitracin showed antimicrobial activities indicating the possibility of overcoming existing limitations just by altering their heterocyclic subunit. Bioactivity and stability can be increased by modifying peptide backbone of compounds.
Export Options
About this article
Cite this article as:
Sharma Kant Chandra and Sharma Monika *, Up Scaling Strategies to Improve the Industrial Production of Bacitracin at Largescale, Mini-Reviews in Medicinal Chemistry 2017; 17 (16) . https://dx.doi.org/10.2174/1389557517666170711165914
DOI https://dx.doi.org/10.2174/1389557517666170711165914 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Adalimumab
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Double Balloon Enteroscopy in Crohn’s Disease: Background and Current State of Play
Current Drug Targets Proton Pump Inhibitors in Pediatrics: Evaluation of Efficacy in GERD Therapy
Current Clinical Pharmacology Cross-Reactive Reactions to Nonsteroidal Anti-Inflammatory Drugs
Current Pharmaceutical Design Crofelemer: In HIV Associated Diarrhea and Secretory Diarrhea - A Patent Perspective
Recent Patents on Anti-Infective Drug Discovery Patent Selections
Recent Patents on Materials Science Challenges and Persistent Questions in the Treatment of Trichomoniasis
Current Topics in Medicinal Chemistry Occipital Encephalocele: Cause, Incidence, Neuroimaging and Surgical Management
Current Pediatric Reviews Evaluation of Topical Black Seed Oil in the Treatment of Allergic Rhinitis
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Immunotherapy in Allergies: An Update
Inflammation & Allergy - Drug Targets (Discontinued) Exhaled Nitric Oxide in Asthma in Adults: The End is the Beginning?
Current Medicinal Chemistry Comparison of High-Sensitive CRP, RDW, PLR and NLR between Patients with Chronic Obstructive Pulmonary Disease and Chronic Heart Failure
Current Respiratory Medicine Reviews Colloidal Polymeric Nanoparticles and Brain Drug Delivery
Current Drug Delivery Novel Approaches To Fight Streptococcus pneumoniae
Recent Patents on Anti-Infective Drug Discovery Comparison of Granulomatosis with Polyangiitis Clinical Features in Patients Depending on Involvement or Absence of Kidney Involvement
Current Rheumatology Reviews Lantibiotic Production by Pathogenic Microorganisms
Current Protein & Peptide Science GH-Inhibitory Activity of Novel Somatostatin Agonists: Potential Applications in Acromegaly
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Immune Therapy for Infectious Diseases at the Dawn of the 21st Century: the Past, Present and Future Role of Antibody Therapy, Therapeutic Vaccination and Biological Response Modifiers
Current Pharmaceutical Design Current Advances in Anti-Influenza Therapy
Current Medicinal Chemistry Repair of Dilated Aortic Root and Sinotubular Junction Using a Stabilizer Ring
Recent Patents on Cardiovascular Drug Discovery